awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q31145542-6BCDB3A4-CEFC-4AAF-A77D-49FDF547D8F1
Q31145542-6BCDB3A4-CEFC-4AAF-A77D-49FDF547D8F1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q31145542-6BCDB3A4-CEFC-4AAF-A77D-49FDF547D8F1
Relationship between baseline characteristics and response to risedronate treatment for osteoporosis: data from three Japanese phase III trials.
P2860
Q31145542-6BCDB3A4-CEFC-4AAF-A77D-49FDF547D8F1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q31145542-6BCDB3A4-CEFC-4AAF-A77D-49FDF547D8F1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
86fc18f0eb888f2aa08233fccfe0690b97791fdf
P2860
Minimum required vitamin D level for optimal increase in bone mineral density with alendronate treatment in osteoporotic women.